Drug Profile
Anakinra biosimilar - Paras Biopharmaceuticals
Alternative Names: PB (RA)-2010Latest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator Paras Biopharmaceuticals Finland
- Class Anti-infectives; Anti-inflammatories; Antibacterials; Antigouts; Antineoplastics; Antirheumatics; Recombinant proteins
- Mechanism of Action Immunomodulators; Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for research development in Rheumatoid-arthritis in Finland (Parenteral)
- 20 May 2015 Early research in Rheumatoid arthritis in Finland (Parenteral) (Paras pipeline, May 2015)